NCT06046807View on ClinicalTrials.gov

Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).

UnknownOBSERVATIONAL
Enrollment

288

Participants

Timeline

Start Date

July 24, 2023

Primary Completion Date

October 24, 2023

Study Completion Date

December 24, 2023

Conditions
Post Thrombotic Syndrome
Interventions
OTHER

Phone call

This follow-up will be conducted over the phone and by mail (some questionnaire may be sent by patient, as per his/her preference)

Trial Locations (1)

Unknown

RECRUITING

ROLLAND, Grenoble

Sponsors

Collaborators (1)

Floralis
All Listed Sponsors
collaborator

Floralis

INDUSTRY

lead

Laboratoires Innothera

INDUSTRY

NCT06046807 - Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term). | Biotech Hunter | Biotech Hunter